<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <title>HTML Practice 5</title>
    <link rel="stylesheet" href="opthalmology.css">
</head>
<body>
<table>
    <caption>Table 1. Stem Cell Companies Active in Opthalmology</caption>
    <tr>
        <th>Company</th>
        <th>Collaborator(s)</th>
        <th>Cell Type</th>
        <th>Applications</th>
    </tr>

    <tr>
        <td class="company">Advanced Cell Technology.</td>
        <td class="collaborators">Oregan Heath & Science
            <ul>
                <li>Moorfields</li>
                <li>UCLA</li>
                <li>Bascom</li>
            </ul>
        </td>
        <td class="celltype">hESCs</td>
        <td class="applications">RPE cells for retinals diseases. AMD <a href="">NCT0143423</a> and Stardgart's <a href="" >NCT032241</a> </td>
    </tr>
    
    <tr>
        <td class="company">Astra Zeneca</td>
        <td class="collaborators">Univ. College London(UCL)</td>
        <td class="celltype">hESCs</td>
        <td class="applications">Diabetic Retinopathy</td>
    </tr>
    
    <tr>
        <td class="company">Centecor/J&J w/ iScience Interventional</td>
        <td class="collaborators">
            <ul>
                <li>Retinal Institute of CA</li>
                <li>Wills Eye Hospital</li>
            </ul>
        </td>
        <td class="celltype">Adult SCs (CNTO 2746 from umbilical cord fluid)</td>
        <td class="applications">RPE Celles for GA (atrophic dry AMD)<a href="">NCT0143423</a></td>
    </tr>
    
    <tr>
        <td class="company">Cell Cure Neurosciences</td>
        <td class="collaborators">TEVA</td>
        <td class="celltype">hESCs</td>
        <td class="applications">RPE for dry AMD</td>
    </tr>
    
    <tr>
        <td class="company">CellSeed France SARL</td>
        <td class="collaborators">FGK Clinical Research GmbH
            <ul>
                <li>Universitatsklinkum, Erlangen, Germany</li>
            </ul>
        </td>
        <td class="celltype">oral mucosa epithelial cells</td>
        <td class="applications">CAOMECS* for Corneal tissue repair in those with limbal cell deficiencies<a href="" >NCT032241</a> </td>
    </tr>
    
    <tr>
        <td class="company">Foundation Clinic per a la Recerca Biomedica (Spain)</td>
        <td class="collaborators">
            <ul>
                <li>Hospital Clinic Barcelona</li>
                <li>Instituto Univ. Barraquer</li>
                <li>Instituto de Microcirugia Ocular</li>
            </ul>
        </td>
        <td class="celltype">sclerocomeal progenitor cells from the limbus</td>
        <td class="applications">Replacement of damaged corneal cells<a href="" >NCT032241</a> </td>
    </tr>
    
    <tr>
        <td class="company">General Hosp of the Chinese People's Armed Police Force(China)</td>
        <td class="collaborators"></td>
        <td class="celltype">Unknown</td>
        <td class="applications">Optic Nerve Atrophy<a href="" >ChiCTR-TNRC-032241</a> </td>
    </tr>
    
    <tr>
        <td class="company">Foundation Clinic per a la Recerca Biomedica (Spain)</td>
        <td class="collaborators">
            <ul>
                <li>Hospital Clinic Barcelona</li>
                <li>Instituto Univ. Barraquer</li>
                <li>Instituto de Microcirugia Ocular</li>
            </ul>
        </td>
        <td class="celltype">hpSCs</td>
        <td class="applications">Replacement of damaged corneal cells<a href="" >NCT032241</a> </td>
    </tr>
</table>
</body>
</html>